Telo Genomics Financials
| 3D0A Stock | EUR 0.06 0.03 93.44% |
Telo |
Understanding current and past Telo Genomics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Telo Genomics' financial statements are interrelated, with each one affecting the others. For example, an increase in Telo Genomics' assets may result in an increase in income on the income statement.
Telo Genomics Stock Summary
Telo Genomics competes with SANOK RUBBER, Singapore Airlines, SINGAPORE AIRLINES, Martin Marietta, and Tencent Music. Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. Telo Genomics Corp. was incorporated in 2011 and is headquartered in Toronto, Canada. TELO GENOMICS operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | CA87975M2085 |
| Business Address | MaRS Centre, Toronto, |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Benchmark | Dow Jones Industrial |
| Website | www.telodx.com |
| Phone | 416 673 8487 |
| Currency | EUR - Euro |
You should never invest in Telo Genomics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Telo Stock, because this is throwing your money away. Analyzing the key information contained in Telo Genomics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Telo Genomics Key Financial Ratios
There are many critical financial ratios that Telo Genomics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Telo Genomics Corp reports annually and quarterly.Telo Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Telo Genomics's current stock value. Our valuation model uses many indicators to compare Telo Genomics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Telo Genomics competition to find correlations between indicators driving Telo Genomics's intrinsic value. More Info.Telo Genomics Corp is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Telo Genomics' earnings, one of the primary drivers of an investment's value.Telo Genomics Corp Systematic Risk
Telo Genomics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Telo Genomics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Telo Genomics Corp correlated with the market. If Beta is less than 0 Telo Genomics generally moves in the opposite direction as compared to the market. If Telo Genomics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Telo Genomics Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Telo Genomics is generally in the same direction as the market. If Beta > 1 Telo Genomics moves generally in the same direction as, but more than the movement of the benchmark.
Telo Genomics November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Telo Genomics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Telo Genomics Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Telo Genomics Corp based on widely used predictive technical indicators. In general, we focus on analyzing Telo Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Telo Genomics's daily price indicators and compare them against related drivers.
| Downside Deviation | 25.95 | |||
| Information Ratio | 0.061 | |||
| Maximum Drawdown | 159.59 | |||
| Value At Risk | (39.85) | |||
| Potential Upside | 52.27 |
Complementary Tools for Telo Stock analysis
When running Telo Genomics' price analysis, check to measure Telo Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telo Genomics is operating at the current time. Most of Telo Genomics' value examination focuses on studying past and present price action to predict the probability of Telo Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telo Genomics' price. Additionally, you may evaluate how the addition of Telo Genomics to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |